Genesis Lifestyle Medicine Review – It Publishes a BMI Criterion, and It Is Low

Across every provider we have reviewed, almost none publishes the BMI at which it will prescribe. Genesis does — and that single act of specificity is worth more than most of what this category writes, because a stated threshold is one you can hold up against the label.

It Publishes a BMI Criterion

The stated eligibility is a BMI over 25 with metabolic symptoms, or a BMI over 30, for people who struggle with weight management despite consistent lifestyle effort and are open to lifestyle guidance.

The structure of the criterion is also right. Splitting it into a lower threshold with a metabolic finding and a higher threshold on its own mirrors how obesity medicine actually works: the presence of a weight-related condition legitimately lowers the bar, because the medication is treating more than a number.

And It Sits Below the Label

Having published a number, Genesis invites the comparison. The approved indication for these medications begins at a BMI of 30, or 27 with at least one weight-related condition. Genesis’s lower tier is 25 with metabolic symptoms.

This is not automatically improper. Prescribing outside a labelled indication is legal, common and sometimes good medicine, and a clinician who examines someone with a BMI of 26 and clear metabolic dysfunction may have sound reasons. The criterion also says metabolic symptoms, not merely a BMI of 25, so it is not an open door.

But the gap is worth knowing before you walk in, for two practical reasons. First, insurance will generally not cover a weight-management GLP-1 below the labelled criteria, so someone in that band is likely paying cash whatever their plan says. Second, being told you qualify is not the same as being told the evidence applies to you — and at a BMI of 26 it does not, at least not from the trials. Our GLP-1 eligibility guide sets out where the thresholds come from.

The point worth holding onto is that we can have this conversation at all because Genesis published the number. The providers with no stated criterion may be prescribing at a BMI of 24 and nobody would know. Specificity invites scrutiny, and that is a reason to reward it, not punish it.

Brand and Compounded, Kept Apart

The medication list separates cleanly: Zepbound and Wegovy as brand-name products, and compounded semaglutide and tirzepatide as distinct alternatives.

This is the second disclosure Genesis gets right, and it is the one we most often find missing. We reviewed a clinic that lists “Ozempic, Wegovy and Semaglutide” under a single price, which makes it impossible to know what you would receive. Genesis lets you choose knowingly, and our compounded versus brand-name guide covers what the choice involves. Phentermine is also offered, which gives an appropriate patient a much cheaper route.

The practice runs 16 locations across Tennessee, Texas, Nevada, Utah, Indiana, Colorado and Florida, with a telehealth option through a separate platform. Follow-ups are scheduled weekly, fortnightly or monthly according to need — a real cadence rather than a vague promise of support.

The Word “Optional”

The medical evaluation is described as including optional laboratory testing.

That word is doing something. A clinic offering labs is better than one that never mentions them, and making them optional respects that some patients arrive with recent bloodwork from their own physician. But it also means a patient can decline, and the eligibility criterion turns on “metabolic symptoms” — a phrase that usually means things bloodwork reveals, such as raised fasting glucose, HbA1c, lipids or markers of insulin resistance.

So the lower BMI tier depends on a finding that optional labs are the natural way to establish. If you are in the 25-to-30 band, that is the specific thing to ask: what metabolic symptom qualifies you, and was it measured or reported? A criterion is only as good as the evidence behind the term it hinges on.

No pricing appears anywhere — not for consultations, medication or labs — and pharmacy arrangements, insurance acceptance and HSA or FSA status are not stated either. For a practice this specific about clinical criteria, the commercial silence is the conspicuous gap.

Provider Facts

Pros and Cons

Who It May Be Best For

A good fit if you live near one of the 16 clinics, want in-person medically supervised care, and want to choose knowingly between an approved product and a compounded one.

Especially if you have a BMI over 30, or over 27 with a weight-related condition — squarely inside the labelled indication, where the evidence and any insurance coverage both apply.

If you are between 25 and 30, ask what metabolic finding qualifies you, and whether it was measured. Ask too whether a GLP-1 is the right first step at that BMI, or whether phentermine or lifestyle work should come first — a practice offering both can answer that honestly.

Get the full price list at the consultation: medication for both the brand and compounded routes, the visit fee, and the labs. None of it is published.

Alternatives

Medi-Weightloss is the closest comparison — a larger clinic network with similarly clear labelling. knownwell bills insurance directly. Blue Sky MD publishes actual medication prices. Our best GLP-1 for weight loss page compares the field.

Limitations of This Review

Based on Genesis Lifestyle Medicine’s own published materials at genesislifestylemedicine.com, checked on 6 September 2026. Locations may operate with differing pricing and policies, so what applies at your nearest clinic may differ. Anything marked not published means we could not find it. The approved indication thresholds we compare against come from the FDA-approved labelling for these medications, not from Genesis, and our observation about the two-point gap is a comparison rather than an allegation of improper prescribing — off-label prescribing is lawful and can be clinically appropriate. Nothing here is medical advice.

Frequently Asked Questions

Verdict

The point worth carrying beyond this provider: reward specificity even when it reveals something you do not like. A company that publishes a threshold you can criticise is being more useful than one that publishes nothing and prescribes to whoever asks — and only the first kind can ever be held to anything.